Drug Type Small molecule drug |
Synonyms Cerlapirdine, PF-05212365, PF-5212365 + [2] |
Target |
Mechanism 5-HT6 receptor antagonists(Serotonin 6 (5-HT6) receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC22H23N3O3S |
InChIKeyNXQGEDVQXVTCDA-UHFFFAOYSA-N |
CAS Registry925448-93-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Cerlapirdine Hydrochloride | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Phase 2 | US | 01 May 2009 | |
Alzheimer Disease | Phase 2 | JP | 01 May 2009 | |
Alzheimer Disease | Phase 2 | AR | 01 May 2009 | |
Alzheimer Disease | Phase 2 | CL | 01 May 2009 | |
Alzheimer Disease | Phase 2 | CO | 01 May 2009 | |
Alzheimer Disease | Phase 2 | HK | 01 May 2009 | |
Alzheimer Disease | Phase 2 | MX | 01 May 2009 | |
Alzheimer Disease | Phase 2 | NZ | 01 May 2009 | |
Alzheimer Disease | Phase 2 | PL | 01 May 2009 | |
Alzheimer Disease | Phase 2 | RO | 01 May 2009 |
Not Applicable | 74 | kufzgjonrx(rakihiipdw) = ddriagdlts uhdzqrvapi (wigdyvcmzc ) | - | 01 Jul 2010 | |||
kufzgjonrx(rakihiipdw) = yypqunevor uhdzqrvapi (wigdyvcmzc ) |